Company registration number 08087502 (England and Wales)
SLOANE SQUARE MEDICAL LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2024
PAGES FOR FILING WITH REGISTRAR
SLOANE SQUARE MEDICAL LTD
BALANCE SHEET
AS AT
31 MAY 2024
31 May 2024
- 1 -
2024
2023
£
£
£
£
Fixed assets
953
3,202
Current assets
145,142
123,308
Prepayments and accrued income
2,860
769
Creditors: amounts falling due within one year
(99,058)
(103,086)
Net current assets
48,944
20,991
Total assets less current liabilities
49,897
24,193
Creditors: amounts falling due after more than one year
(49,876)
(23,291)
Net assets
21
902
Capital and reserves
21
902
Notes to the financial statements
1
Director's benefits: advances, credit and guarantees
Directors' Loan Account

During the year, a total of £150,501 (2023: £103,918) was advanced to and a total of £131,990 (2023: £89,683) was credited by the directors in respect of their directors' current account. Interest totalling £3,322 (2023: £2,592) was charged on this balance. At the balance sheet date the amount due to the directors was £145,142 (2023: £123,309).

2
Employees

The average number of persons, including directors, employed by the company during the year was as follows:

2024
2023
Number
Number
Employees
4
2
SLOANE SQUARE MEDICAL LTD
BALANCE SHEET (CONTINUED)
AS AT
31 MAY 2024
31 May 2024
- 2 -

Sloane Square Medical Ltd is a private company limited by shares incorporated in England and Wales. The registered office is 2 Lower Sloane Street, Chelsea, London, SW1W 8BJ.

For the year ended 31 May 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared in accordance with the micro-entity provisions and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime' and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

 

In previous years the financial statements have been prepared under Section 1A of FRS102. During the current financial year, the company transitioned to FRS105 reporting, including restating comparatives in accordance (including removing deferred tax not allowed under FRS105). Reserves at 31 May 2023 under Section 1A of FRS102 were £2. Reserves at 31 May 2023 under FRS105 have been restated to £902.

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved and signed by the director and authorised for issue on 27 February 2025
Dr V Owen
Director
Company registration number 08087502 (England and Wales)
2024-05-312023-06-01falsefalseCCH SoftwareCCH Accounts Production 2024.310No description of principal activityDr V Owenfalse080875022023-06-012024-05-31080875022024-05-31080875022023-05-3108087502core:CurrentFinancialInstrumentscore:WithinOneYear2024-05-3108087502core:CurrentFinancialInstrumentscore:WithinOneYear2023-05-3108087502core:Non-currentFinancialInstruments2024-05-3108087502core:Non-currentFinancialInstruments2023-05-31080875022022-06-012023-05-3108087502bus:Director12023-06-012024-05-3108087502bus:PrivateLimitedCompanyLtd2023-06-012024-05-3108087502bus:SmallCompaniesRegimeForAccounts2023-06-012024-05-3108087502bus:Micro-entities2023-06-012024-05-3108087502bus:AuditExemptWithAccountantsReport2023-06-012024-05-3108087502bus:FullAccounts2023-06-012024-05-31xbrli:purexbrli:sharesiso4217:GBP